An empirical model to predict survival curve and relative biological effectiveness after helium and carbon ion irradiation based solely on the cell survival after photon irradiation
D. B. Flint, S. J. Bright, C. H. McFadden, T. Konishi, D. Ohsawa, A. Kobayashi, S. F. Shaitelman, G. O. Sawakuchi
Abstract
PurposeTo develop an empirical model to predict radiosensitivity and relative biological effectiveness (RBE) after helium (He) and carbon (C) ion irradiation with or without DNA repair inhibitors. MethodsWe characterized survival in eight human cancer cell lines exposed to 6 MV photons and to He- and C-ions with linear energy transfer (LET) values of 2.2-60.5 keV/m to verify that the radiosensitivity parameters (D5%, D10%, D20%, D37%, D50% and SF2Gy) correlate linearly between photon and ion radiation with or without DNA-PKcs or ATR inhibitors. Then, we parameterized the LET response of the parameters governing these linear correlations up to LET values of 225 keV/m using the data in the Particle Irradiation Data Ensemble (PIDE) v3.2 database, creating a model that predicts a cells ion radiosensitivity, RBE and ion survival curve for a given LET on the basis of the cells photon radiosensitivity. We then trained this model using the PIDE database as a training dataset, and validated it by predicting the radiosensitivity of the cell lines we exposed to He- and C- ions with LET ranging from 2.2-60.5 keV/m. ResultsRadiosensitivity to ions depended linearly with radiosensitivity of photons in the range of investigated LET values and the slopes and intercepts of these linear relationships within the PIDE database vary exponentially and linearly, respectively. Our model predicted ion radiosensitivity (e.g., D10%) within 5.1-21.3%, RBED10% within 5.0-17.1%, and ion mean inactivation dose within 6.7-25.1% for He- and C-ion LET ranging from 2.2-60.5 keV/m. ConclusionsRadiosensitivity to He- and C-ions depend linearly with radiosensitivity to photons and can be used to predict ion radiosensitivity, RBE and cell survival curves for clinically relevant LET values from 2.2-60.5 keV/m, with or without drug treatment. SUMMARYWe present a new empirical model capable of predicting clonogenic cell survival of cell lines exposed to helium and carbon ion beams. Our model is based on an observed linear correlation between radiosensitivity to ions and photons across a wide range of LET values. This linear correlation can be used to predict ion RBE, radiosensitivity, and the cell survival curve for a given LET all based on a cells photon survival curve.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell lines of the same anatomic site and histologic type show large variability in intrinsic radiosensitivity and relative biological effectiveness to protons and carbon ions
D. B. Flint, S. J. Bright, … G. O. Sawakuchi·bioRxiv·Jun 19, 2020
- Clonogenic survival and relative biological effectiveness of pancreatic ductal adenocarcinoma under pristine and spread-out Bragg peak irradiation with protons and carbon ions.
Janet M. Denbeigh, Alexandra Kneringer, … Chris J Beltran·bioRxiv·Oct 1, 2026
- DNA break clustering inside repair domains predicts cell death and mutation frequency in human fibroblasts and in Chinese hamster cells for a 10^3x range of linear energy transfers
E. Pariset, I. Plante, … S. V. Costes·bioRxiv·Nov 30, 2020
- Effects of G2 checkpoint dynamics on the low-dose hyper-radiosensitivity
O. Olobatuyi, G. de Vries, T. Hillen·bioRxiv·Sep 12, 2017
- Differential biological effect of low doses of ionizing radiation depending on the radiosensitivity in a cell line model
Elia Palma-Rojo, Joan Francesc Barquinero, … Gemma Armengol·International Journal of Radiation BiologyPeer-reviewed·Sep 17, 2024
- LET-dependence of radiation-induced makers of Immunogenic Cell Death in human cancer cell lines
B. Ponnaiya, A. Lomastro, … D. J. Brenner·bioRxiv·Jan 25, 2022